ASPIRE for Lung Cancer shared a post on LinkedIn:
“ASPIRE had recently convened the 3rd edition of the Hong Kong Roundtable series, bringing together clinicians, academics and health system leaders to advance practical solutions across the lung cancer care continuum, with a focus on improving how patients move from diagnosis to timely, equitable treatment.
Hong Kong’s lung cancer landscape is evolving quickly. While innovation is expanding the standard of care, real-world access and pathway readiness need to keep pace, so that clinical progress translates into better outcomes for patients.
The 3rd roundtable focused on:
- Closing access gaps to innovative NSCLC treatments
Next step: Explore more sustainable funding and access mechanisms that better match today’s treatment paradigm.
- Reducing diagnostic-to-treatment delays (staging, biopsy, molecular testing)
Next step: Strengthen pathway coordination and testing readiness to support timely decision-making.
- Strengthening MDT coordination and real-world implementation
Next step: Improve operational alignment so evidence-based practice is feasible across settings.
- Supporting readiness for earlier-stage interventions
Next step: Continue clinician and system education, and align processes that enable appropriate uptake.
A huge thank you to all participants for your time and leadership, Herbert Loong, Martin Chi-Sang Wong, Rina Hui, William Chui, Elaine Chow, James Ho, Michael Hsin, Li Ki Kwong, Molly Li. We also thank our partners and co-hosts, The Chinese University of Hong Kong-CHEHP and Asia Pacific Coalition against Lung Cancer, for jointly supporting this series with ASPIRE.”
Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, and Steering Committee Member at Lung Cancer Policy Network, shared this post, adding:
“A pleasure working with multiple stake holders and like minded colleagues in Hong Kong to push the agenda of improving lung cancer health – from early detection to drug access forward.”

More posts featuring ASPIRE for Lung Cancer on OncoDaily.